Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)
[PMS] LINZESS® Tablet 0.25mg Long-term Specified Drug Use-results Survey in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)
Sponsor: Astellas Pharma Inc
Listed as NCT03471728, this observational or N/A phase trial focuses on Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases) and Irritable Bowel Syndrome With Constipation (IBS-C) and remains completed. Sponsored by Astellas Pharma Inc, it has been updated 28 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
28 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Nov 2024 — Sep 2025 [monthly]
Completed
-
Sep 2024 — Nov 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 23 earlier versions
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Mar 2021 — May 2021 [monthly]
Active Not Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Aug 2020 — Oct 2020 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
-
May 2020 — Jul 2020 [monthly]
Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Recruiting
-
Aug 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Recruiting
-
Dec 2018 — Jun 2019 [monthly]
Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Oct 2018 [monthly]
Recruiting
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Astellas Pharma Inc
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aichi, Japan , Akita, Japan , Aomori, Japan , Chiba, Japan , Ehime, Japan , Fukui, Japan , Fukuoka, Japan , Fukushima, Japan , Gifu, Japan , Gunma, Japan and 37 more locations